Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer - Authors reply Journal Article
| Authors: | Saltz, L. B.; Miller, L. L. |
| Article Title: | Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer - Authors reply |
| Keywords: | survival; cancer survival; controlled study; human tissue; survival analysis; human cell; major clinical study; clinical trial; fluorouracil; cancer combination chemotherapy; diarrhea; dose response; note; antineoplastic agent; letter; colorectal cancer; metastasis; quality of life; controlled clinical trial; mucosa inflammation; randomized controlled trial; antineoplastic combined chemotherapy protocols; camptothecin; pathology; irinotecan; colorectal neoplasms; cost effectiveness analysis; economics; colorectal tumor; folinic acid; neoplasm metastasis; drug derivative; leucovorin; cost-benefit analysis; socioeconomics; cost benefit analysis; humans; human; priority journal; value of life |
| Journal Title: | New England Journal of Medicine |
| Volume: | 344 |
| Issue: | 4 |
| ISSN: | 0028-4793 |
| Publisher: | Massachusetts Medical Society |
| Date Published: | 2001-01-25 |
| Start Page: | 306 |
| End Page: | 307 |
| Language: | English |
| DOI: | 10.1056/nejm200101253440413 |
| PUBMED: | 11191660 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
